Cyclic 3′,5′-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia

In Kiu Kwon, Rui Wang, Nikhil Prakash, Renee Bozard, Troy A. Baudino, Kebin Liu, Muthusamy Thangaraju, Zheng Dong, Darren D Browning

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Type 1 cyclic 3′,5′-guanosine monophosphate- dependent protein kinase (PKG) has recently been reported to inhibit tumor growth and angiogenesis. These effects suggest that PKG activation may have therapeutic value for colon cancer treatment, but the signaling downstream of this enzyme is poorly understood. The present study examined the mechanism underlying the inhibition of angiogenesis by PKG. METHODS: The effect of ectopically expressed PKG on colon cancer cell adaptation to a 1% O2 (hypoxic) environment was examined in vitro by measuring hypoxic markers, cell death/viability, and hypoxia inducible factor (HIF) activity. RESULTS: Ectopic PKG inhibited angiogenesis in SW620 xenografts and significantly attenuated hypoxia-induced increases in vascular endothelial growth factor at both the mRNA and protein levels. PKG activation also blocked hypoxia-induced hexokinase 2 expression, which corresponded with reduced cellular adenosine triphosphate levels. Moreover, PKG expression significantly reduced cell viability and promoted necrotic cell death after 2 days in a hypoxic environment. To gain some mechanistic insight, the effect of PKG on HIF activation was determined using luciferase reporter assays. PKG activation inhibited HIF transcriptional activity in several colon cancer cell lines, including SW620, HCT116, and HT29. The mechanism by which PKG can inhibit HIF activity is not known, but it does not affect HIF-1α protein accumulation or nuclear translocation. CONCLUSIONS: These findings demonstrate for the first time that PKG can block the adaptation of colon cancer cells to hypoxia and highlights this enzyme for further evaluation as a potential target for colon cancer treatment.

Original languageEnglish (US)
Pages (from-to)5282-5293
Number of pages12
JournalCancer
Volume117
Issue number23
DOIs
StatePublished - Dec 1 2011

Fingerprint

Colonic Neoplasms
Protein Kinases
Cell Hypoxia
Cell Survival
Cell Death
Hypoxia-Inducible Factor 1
Hexokinase
Enzymes
Luciferases
Heterografts
Vascular Endothelial Growth Factor A
Proteins
Adenosine Triphosphate
3'-guanylic acid
Hypoxia
Cell Line
Messenger RNA
Growth
Neoplasms
Therapeutics

Keywords

  • angiogenesis
  • colon
  • cyclic 3′;5′-guanosine monophosphate
  • hypoxia
  • kinase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cyclic 3′,5′-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia. / Kwon, In Kiu; Wang, Rui; Prakash, Nikhil; Bozard, Renee; Baudino, Troy A.; Liu, Kebin; Thangaraju, Muthusamy; Dong, Zheng; Browning, Darren D.

In: Cancer, Vol. 117, No. 23, 01.12.2011, p. 5282-5293.

Research output: Contribution to journalArticle

Kwon, In Kiu ; Wang, Rui ; Prakash, Nikhil ; Bozard, Renee ; Baudino, Troy A. ; Liu, Kebin ; Thangaraju, Muthusamy ; Dong, Zheng ; Browning, Darren D. / Cyclic 3′,5′-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia. In: Cancer. 2011 ; Vol. 117, No. 23. pp. 5282-5293.
@article{902056f0b0534fad87eefa1e6f082584,
title = "Cyclic 3′,5′-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia",
abstract = "Background: Type 1 cyclic 3′,5′-guanosine monophosphate- dependent protein kinase (PKG) has recently been reported to inhibit tumor growth and angiogenesis. These effects suggest that PKG activation may have therapeutic value for colon cancer treatment, but the signaling downstream of this enzyme is poorly understood. The present study examined the mechanism underlying the inhibition of angiogenesis by PKG. METHODS: The effect of ectopically expressed PKG on colon cancer cell adaptation to a 1{\%} O2 (hypoxic) environment was examined in vitro by measuring hypoxic markers, cell death/viability, and hypoxia inducible factor (HIF) activity. RESULTS: Ectopic PKG inhibited angiogenesis in SW620 xenografts and significantly attenuated hypoxia-induced increases in vascular endothelial growth factor at both the mRNA and protein levels. PKG activation also blocked hypoxia-induced hexokinase 2 expression, which corresponded with reduced cellular adenosine triphosphate levels. Moreover, PKG expression significantly reduced cell viability and promoted necrotic cell death after 2 days in a hypoxic environment. To gain some mechanistic insight, the effect of PKG on HIF activation was determined using luciferase reporter assays. PKG activation inhibited HIF transcriptional activity in several colon cancer cell lines, including SW620, HCT116, and HT29. The mechanism by which PKG can inhibit HIF activity is not known, but it does not affect HIF-1α protein accumulation or nuclear translocation. CONCLUSIONS: These findings demonstrate for the first time that PKG can block the adaptation of colon cancer cells to hypoxia and highlights this enzyme for further evaluation as a potential target for colon cancer treatment.",
keywords = "angiogenesis, colon, cyclic 3′;5′-guanosine monophosphate, hypoxia, kinase",
author = "Kwon, {In Kiu} and Rui Wang and Nikhil Prakash and Renee Bozard and Baudino, {Troy A.} and Kebin Liu and Muthusamy Thangaraju and Zheng Dong and Browning, {Darren D}",
year = "2011",
month = "12",
day = "1",
doi = "10.1002/cncr.26192",
language = "English (US)",
volume = "117",
pages = "5282--5293",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "23",

}

TY - JOUR

T1 - Cyclic 3′,5′-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia

AU - Kwon, In Kiu

AU - Wang, Rui

AU - Prakash, Nikhil

AU - Bozard, Renee

AU - Baudino, Troy A.

AU - Liu, Kebin

AU - Thangaraju, Muthusamy

AU - Dong, Zheng

AU - Browning, Darren D

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background: Type 1 cyclic 3′,5′-guanosine monophosphate- dependent protein kinase (PKG) has recently been reported to inhibit tumor growth and angiogenesis. These effects suggest that PKG activation may have therapeutic value for colon cancer treatment, but the signaling downstream of this enzyme is poorly understood. The present study examined the mechanism underlying the inhibition of angiogenesis by PKG. METHODS: The effect of ectopically expressed PKG on colon cancer cell adaptation to a 1% O2 (hypoxic) environment was examined in vitro by measuring hypoxic markers, cell death/viability, and hypoxia inducible factor (HIF) activity. RESULTS: Ectopic PKG inhibited angiogenesis in SW620 xenografts and significantly attenuated hypoxia-induced increases in vascular endothelial growth factor at both the mRNA and protein levels. PKG activation also blocked hypoxia-induced hexokinase 2 expression, which corresponded with reduced cellular adenosine triphosphate levels. Moreover, PKG expression significantly reduced cell viability and promoted necrotic cell death after 2 days in a hypoxic environment. To gain some mechanistic insight, the effect of PKG on HIF activation was determined using luciferase reporter assays. PKG activation inhibited HIF transcriptional activity in several colon cancer cell lines, including SW620, HCT116, and HT29. The mechanism by which PKG can inhibit HIF activity is not known, but it does not affect HIF-1α protein accumulation or nuclear translocation. CONCLUSIONS: These findings demonstrate for the first time that PKG can block the adaptation of colon cancer cells to hypoxia and highlights this enzyme for further evaluation as a potential target for colon cancer treatment.

AB - Background: Type 1 cyclic 3′,5′-guanosine monophosphate- dependent protein kinase (PKG) has recently been reported to inhibit tumor growth and angiogenesis. These effects suggest that PKG activation may have therapeutic value for colon cancer treatment, but the signaling downstream of this enzyme is poorly understood. The present study examined the mechanism underlying the inhibition of angiogenesis by PKG. METHODS: The effect of ectopically expressed PKG on colon cancer cell adaptation to a 1% O2 (hypoxic) environment was examined in vitro by measuring hypoxic markers, cell death/viability, and hypoxia inducible factor (HIF) activity. RESULTS: Ectopic PKG inhibited angiogenesis in SW620 xenografts and significantly attenuated hypoxia-induced increases in vascular endothelial growth factor at both the mRNA and protein levels. PKG activation also blocked hypoxia-induced hexokinase 2 expression, which corresponded with reduced cellular adenosine triphosphate levels. Moreover, PKG expression significantly reduced cell viability and promoted necrotic cell death after 2 days in a hypoxic environment. To gain some mechanistic insight, the effect of PKG on HIF activation was determined using luciferase reporter assays. PKG activation inhibited HIF transcriptional activity in several colon cancer cell lines, including SW620, HCT116, and HT29. The mechanism by which PKG can inhibit HIF activity is not known, but it does not affect HIF-1α protein accumulation or nuclear translocation. CONCLUSIONS: These findings demonstrate for the first time that PKG can block the adaptation of colon cancer cells to hypoxia and highlights this enzyme for further evaluation as a potential target for colon cancer treatment.

KW - angiogenesis

KW - colon

KW - cyclic 3′;5′-guanosine monophosphate

KW - hypoxia

KW - kinase

UR - http://www.scopus.com/inward/record.url?scp=81755184360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81755184360&partnerID=8YFLogxK

U2 - 10.1002/cncr.26192

DO - 10.1002/cncr.26192

M3 - Article

C2 - 21563174

AN - SCOPUS:81755184360

VL - 117

SP - 5282

EP - 5293

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 23

ER -